Ayse U. Akarca

ORCID: 0000-0003-0629-3927
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Lymphoma Diagnosis and Treatment
  • Gastrointestinal Tumor Research and Treatment
  • Synthesis and pharmacology of benzodiazepine derivatives
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Immune Cell Function and Interaction
  • Protein Degradation and Inhibitors
  • Monoclonal and Polyclonal Antibodies Research
  • Immune responses and vaccinations
  • Cancer therapeutics and mechanisms
  • Radiomics and Machine Learning in Medical Imaging
  • Ferroptosis and cancer prognosis
  • CAR-T cell therapy research
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Single-cell and spatial transcriptomics
  • Chronic Lymphocytic Leukemia Research
  • DNA Repair Mechanisms
  • Neutropenia and Cancer Infections
  • Hepatocellular Carcinoma Treatment and Prognosis

University College London
2016-2025

University College Hospital
2017-2025

Royal London Hospital
2016-2024

CRUK Lung Cancer Centre of Excellence
2016-2024

University of Pennsylvania
2023

University College London Hospitals NHS Foundation Trust
2017-2022

London Cancer
2017-2021

University of London
2020

Cancer Research UK
2017

UCL Australia
2014

The cellular ancestry of tumor antigens One contributing factor in antitumor immunity is the repertoire neoantigens created by genetic mutations within cells. Like corresponding mutations, these show intratumoral heterogeneity. Some are present all cells (clonal), and others only a fraction (subclonal). In study lung cancer melanoma, McGranahan et al. found that high burden clonal correlated with improved patient survival, an increased presence tumor-infiltrating lymphocytes, durable...

10.1126/science.aaf1490 article EN Science 2016-03-04
Christopher Abbosh Nicolai J. Birkbak Gareth A. Wilson Mariam Jamal‐Hanjani T Constantin and 95 more Raheleh Salari John Le Quesne David A. Moore Selvaraju Veeriah Rachel Rosenthal Teresa Marafioti Eser Kırkızlar Anne Thomas Nicholas McGranahan Sophia Ward Luke Martinson Joan Riley Francesco Fraioli Maise Al Bakir Eva Grönroos Francisco Zambrana Raymondo Endozo Wenya Linda Bi Fiona M. Fennessy Nicole Sponer Diana Johnson Joanne Laycock Seema Shafi Justyna Czyzewska-Khan Andrew Rowan Tim Chambers Nik Matthews Samra Turajlic Crispin T. Hiley SM Lee Martin Förster Tanya Ahmad Mary Falzon Elaine Borg David Lawrence Sophia Ward Shyam Kolvekar Nikolaos Panagiotopoulos Sam M. Janes Ricky M. Thakrar Asia Ahmed Fiona Blackhall Yvonne Summers Dina Hafez Ashwini Naik Apratim Ganguly Stephanie Kareht Rajesh Shah Leena Dennis Joseph Anne Marie Quinn Philip Crosbie Babu Naidu Gary Middleton Gerald Langman Simon Trotter M. Nicolson Hardy Remmen Keith M. Kerr Mahendran Chetty Lesley Gomersall Dean A. Fennell Apostolos Nakas Sridhar Rathinam Girija Anand Sajid Khan Peter Russell Veni Ezhil Babikir Ismail Melanie Irvin-Sellers Vineet Prakash J.F. Lester Malgorzata Kornaszewska Richard Attanoos Haydn Adams Helen Davies Dahmane Oukrif Ayse U. Akarca John A. Hartley Helen L. Lowe Sara Lock Natasha Iles Harriet Bell Yenting Ngai Greg Elgar Zoltán Szállási Roland F. Schwarz Javier Herrero Grant D. Stewart Sergio A. Quezada Karl S. Peggs Peter Van Loo Caroline Dive C Jimmy Lin Matthew Rabinowitz Hugo J.W.L. Aerts

10.1038/nature22364 article EN Nature 2017-04-25
Lewis Au Emine Hatipoglu Marc Robert de Massy Kevin Litchfield Gordon Beattie and 95 more Andrew Rowan Désirée Schnidrig R. Houston Thompson Fiona Byrne Stuart Horswell Nicos Fotiadis Steve Hazell David Nicol Scott T.C. Shepherd Annika Fendler Robert M. Mason Lyra Del Rosario Kim Edmonds Karla Lingard Sarah Sarker Mary Mangwende Eleanor Carlyle Jan Attig Kroopa Joshi Imran Uddin Pablo D. Becker Mariana Werner Sunderland Ayse U. Akarca Ignazio Puccio William Yang Tom Lund Kim Dhillon Marcos Duran Vasquez Ehsan Ghorani Hang Xu Charlotte Spencer José I. López Anna Green Ula Mahadeva Elaine Borg Miriam Mitchison David A. Moore Ian Proctor Mary Falzon Lisa Pickering Andrew J.S. Furness James L. Reading Roberto Salgado Teresa Marafioti Mariam Jamal‐Hanjani George Kassiotis Benny Chain James Larkin Charles Swanton Sergio A. Quezada Samra Turajlic Chris Abbosh Kai‐Keen Shiu John Bridgewater Daniel Hochhauser Martin Förster SM Lee Tanya Ahmad Dionysis Papadatos-Pastos Sam M. Janes Peter Van Loo Katey S.S. Enfield Nicholas McGranahan Ariana Huebner Stephan Beck Peter J. Parker Henning Walczak Tariq Enver Robert E. Hynds Ron Sinclair Chi-wah Lok Zoe Rhodes David A. Moore Reena Khiroya Giorgia Trevisan Peter Ellery Mark Linch Sebastian Brandner Crispin T. Hiley Selvaraju Veeriah Maryam Razaq Heather Shaw G. Attard Mita Afroza Akther Cristina Naceur‐Lombardelli Lizi Manzano Maise Al-Bakir Simranpreet Summan Nnenna Kanu Sophia Ward Uzma Asghar Emilia L. Lim Faye Gishen Adrian Tookman Paddy Stone

ADAPTeR is a prospective, phase II study of nivolumab (anti-PD-1) in 15 treatment-naive patients (115 multiregion tumor samples) with metastatic clear cell renal carcinoma (ccRCC) aiming to understand the mechanism underpinning therapeutic response. Genomic analyses show no correlation between molecular features and response, whereas ccRCC-specific human endogenous retrovirus expression indirectly correlates clinical T receptor (TCR) analysis reveals significantly higher number expanded TCR...

10.1016/j.ccell.2021.10.001 article EN cc-by Cancer Cell 2021-10-28

Background Modulation of adaptive immunity may underscore the efficacy trans-arterial chemoembolization (TACE). We evaluated influence TACE on T-cell function by phenotypic lymphocyte characterization in samples patients undergoing surgery with (T+) or without (T-) prior-TACE treatment. Methods profiled intratumoral (IT), peritumoral (PT) and non-tumoral (NT) background tissue to evaluate regulatory CD4+/FOXP3+ (T-reg) immune-exhausted CD8+/PD-1+ T-cells across T+ (n=58) T− (n=61). performed...

10.1136/jitc-2021-003311 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2021-09-01

Abstract Understanding the role of tumor microenvironment (TME) in lung cancer is critical to improving patient outcomes. We identified four histology-independent archetype TMEs treatment-naïve early-stage using imaging mass cytometry TRACERx study (n = 81 patients/198 samples/2.3 million cells). In immune-hot adenocarcinomas, spatial niches T cells and macrophages increased with clonal neoantigen burden, whereas such an increase was observed for plasma B immune-excluded squamous cell...

10.1158/2159-8290.cd-23-1380 article EN cc-by Cancer Discovery 2024-04-06

Abstract Despite the many advances in treatment of hematologic malignancies over past decade, outcomes refractory lymphomas remain poor. One potential strategy this patient population is specific targeting IL2R-α (CD25), which overexpressed on lymphoma and leukemic cells, using antibody–drug conjugates (ADC). ADCT-301 an ADC composed human IgG1 HuMax-TAC against CD25, stochastically conjugated through a dipeptide cleavable linker to pyrrolobenzodiazepine (PBD) dimer warhead with...

10.1158/1535-7163.mct-16-0233 article EN Molecular Cancer Therapeutics 2016-08-18

Abstract APOBEC3 enzymes are cytosine deaminases implicated in cancer. Precisely when expression is induced during cancer development remains to be defined. Here we show that specific genes upregulated breast ductal carcinoma situ, and preinvasive lung lesions coincident with cellular proliferation. We observe evidence of APOBEC3-mediated subclonal mutagenesis propagated from TRACERx invasive non–small cell (NSCLC) lesions. find APOBEC3B exacerbates DNA replication stress chromosomal...

10.1158/2159-8290.cd-20-0725 article EN Cancer Discovery 2021-05-04

The linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, is required for optimal TNF-mediated gene activation to prevent cell death induced by TNF. Here, we demonstrate that keratinocyte-specific deletion HOIP or (E-KO) results in severe dermatitis causing postnatal lethality. We provide genetic pharmacological evidence the lethal HoipE-KO Hoil-1E-KO mice caused TNFR1-induced, caspase-8-mediated apoptosis occurs independently kinase activity RIPK1. In...

10.1038/s41467-018-06155-8 article EN cc-by Nature Communications 2018-09-19

Programmed cell death ligand-1 immunohistochemical detection (PD-L1 IHC) is a putative predictor of response to PD-1/PD-L1-targeted checkpoint inhibitors. However, there no gold standard assay in hepatocellular carcinoma (HCC). We evaluated 5 PD-L1 IHC platforms (E1LN3, 28-8, 22c3, SP263 and SP142) 100 HCCs reporting expression malignant (M) tumour-infiltrating immune cells (TICs) non-tumorous cirrhotic tissues (NTICs). found substantial inter-assay heterogeneity detecting M (R2 =...

10.1038/s41416-019-0466-x article EN cc-by British Journal of Cancer 2019-05-01

Abstract Before squamous cell lung cancer develops, precancerous lesions can be found in the airways. From longitudinal monitoring, we know that only half of such become cancer, whereas a third spontaneously regress. Although recent studies have described presence an active immune response high-grade lesions, mechanisms underpinning clinical regression remain unknown. Here, show host surveillance is strongly implicated lesion regression. Using bronchoscopic biopsies from human subjects, find...

10.1158/2159-8290.cd-19-1366 article EN Cancer Discovery 2020-07-20

Abstract Beyond tertiary lymphoid structures, a significant number of immune-rich areas without germinal center-like structures are observed in non–small cell lung cancer. Here, we integrated transcriptomic data and digital pathology images to study the prognostic implications, spatial locations, constitution immune rich (immune hotspots) cohort 935 patients with cancer from The Cancer Genome Atlas. A high intratumoral hotspot score, which measures proportion hotspots interfacing tumor...

10.1158/0008-5472.can-22-2589 article EN cc-by Cancer Research 2023-02-28
Robert E. Hynds Ariana Huebner David R. Pearce Mark S. Hill Ayse U. Akarca and 95 more David A. Moore Sophia Ward Kate H.C. Gowers Takahiro Karasaki Maise Al Bakir Gareth A. Wilson Oriol Pich Carlos Martínez‐Ruiz Arman Hossain Simon P. Pearce Monica Sivakumar Assma Ben Aïssa Eva Grönroos Deepak P. Chandrasekharan Krishna K. Kolluri Rebecca Towns Kaiwen Wang Daniel E. Cook Leticia Bosshard‐Carter Cristina Naceur‐Lombardelli Andrew J. Rowan Selvaraju Veeriah Kevin Litchfield Philip Crosbie Caroline Dive Sergio A. Quezada Sam M. Janes Mariam Jamal‐Hanjani Teresa Marafioti Maise Al Bakir J.F. Lester Amrita Bajaj Apostolos Nakas Azmina Sodha-Ramdeen Mohamad Tufail Molly Scotland Rebecca Boyles Sridhar Rathinam Claire Wilson Domenic Marrone Sean Dulloo Dean A. Fennell Gurdeep Matharu Jacqui Shaw Ekaterini Boleti Heather Cheyne Mohammed S. Khalil Shirley Richardson Tracey Cruickshank Gillian Price Keith M. Kerr Sarah Benafif Jack French Kayleigh Gilbert Babu Naidu Akshay J. Patel Aya Osman Carol Enstone Gerald Langman Helen Shackleford Madava Djearaman Salma Kadiri Gary Middleton Angela Leek Jack Davies Hodgkinson Nikki Totton Ángeles Montero Elaine Smith Eustace Fontaine Felice Granato António Paiva‐Correia Juliette Novasio Kendadai Rammohan Leena Dennis Joseph Paul Bishop Rajesh Shah Stuart Moss Vijay V. Joshi Kate Brown Mathew Carter Anshuman Chaturvedi Pedro Oliveira Colin R. Lindsay Fiona Blackhall Matthew Krebs Yvonne Summers Alexandra Clipson Jonathan Tugwood Alastair Kerr Dominic G. Rothwell Hugo J.W.L. Aerts Roland F. Schwarz Tom L. Kaufmann Rachel Rosenthal Peter Van Loo

Patient-derived xenograft (PDX) models are widely used in cancer research. To investigate the genomic fidelity of non-small cell lung PDX models, we established 48 from 22 patients enrolled TRACERx study. Multi-region tumor sampling increased successful engraftment and most were histologically similar to their parent tumor. Whole-exome sequencing enabled comparison tumors provide an adapted mouse reference genome for improved removal NOD scid gamma (NSG) mouse-derived reads data. model...

10.1038/s41467-024-47547-3 article EN cc-by Nature Communications 2024-05-31

Few studies were conducted investigating the immunological profiles in gastrointestinal stromal tumors (GIST). Adaptive and innate immune cells are present tumor microenvironment, indicating GIST as inflamed tumors. In addition, murine models suggested a potential interaction between components imatinib. this retrospective study, profile was investigated through silico analysis immunohistochemistry (IHC), exploring basis for immunotherapy approaches. Gene expression (GEP) from 31...

10.1080/2162402x.2019.1617588 article EN OncoImmunology 2019-06-04

Abstract Myasthenia gravis (MG) is an autoimmune disease characterized by impaired neuromuscular signaling due to autoantibodies targeting the acetylcholine receptor. Although its auto-antigens and effector mechanisms are well defined, cellular molecular drivers underpinning MG remain elusive. Here, we employed high-dimensional single-cell mass spectral cytometry of blood thymus samples from patients in combination with supervised unsupervised machine-learning tools gain insight into immune...

10.1007/s00401-021-02299-y article EN cc-by Acta Neuropathologica 2021-03-28

BackgroundIntratumoural heterogeneity (ITH) is well recognised in prostate cancer (PC), but its role high-risk disease uncertain. A prospective, single-arm, translational study using targeted multiregion biopsies was carried out to genomic and T-cell ITH clinically PC aiming identify drivers potential therapeutic strategies.Patients methodsForty-nine men with elevated prostate-specific antigen multiparametric-magnetic resonance imaging detected underwent image-guided transperineal biopsy....

10.1093/annonc/mdx355 article EN cc-by Annals of Oncology 2017-07-18

Dendritic cells (DC) are specialized mononuclear phagocytes that link innate and adaptive immunity. They comprise two principal subsets: plasmacytoid DC (pDC) conventional (cDC). Understanding the generation, differentiation, migration of cDC is critical for immune homeostasis. Through human in vivo deuterium-glucose labeling, we observed rapid appearance AXL+ Siglec6+ (ASDC) bloodstream. ASDC circulate ∼2.16 days, while cDC1 DC2 ∼1.32 ∼2.20 respectively, upon release from bone marrow....

10.1084/jem.20220867 article EN The Journal of Experimental Medicine 2024-09-14
Coming Soon ...